ALLO - Allogene Therapeutics, Inc.
2.26
-0.150 -6.637%
Share volume: 6,330,340
Last Updated: 03-27-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
-0.04%
PREVIOUS CLOSE
CHG
CHG%
$2.41
-0.15
-0.06%
View ratios
| Fiscal Date | 03-31-2024 | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q1 2024 | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | |
| Report Date | 05-13-2024 | 08-07-2024 | 11-07-2024 | 03-13-2025 | 05-13-2025 | 08-13-2025 | 11-06-2025 | 03-12-2026 | |
| Cash flow financing | 1.650 M | 108.603 M | 679.000 K | 5.743 M | 13.990 M | 5.072 M | 3.236 M | 7.859 M | |
| Other financing cash flows | 0.000 | 0.000 | 0.000 | 0.000 | 3.350 M | 3.558 M | 0.000 | 0.000 | |
| Cash flow | -32.116 M | 119.628 M | -119.428 M | 23.979 M | -32.763 M | 9.877 M | -14.517 M | 13.873 M | |
| Net income | -65.000 M | -66.358 M | -66.293 M | -59.939 M | -59.733 M | -50.943 M | -41.400 M | -38.810 M | |
| Depreciation | 3.555 M | 3.644 M | 3.207 M | 3.233 M | 3.099 M | 3.106 M | 3.097 M | 3.057 M | |
| Changes in inventories | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Changes in receivables | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Cashflow | 22.133 M | 74.613 M | -75.992 M | 54.934 M | 6.176 M | 43.835 M | 11.935 M | 33.613 M | |
| Net Borrowings | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Investing Activity Other | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Dividends Paid | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Exchange Rate Effect | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Capital Expenditures | 8.000 K | 0.000 | 429.000 K | 257.000 K | 99.000 K | 44.000 K | 243.000 K | 0.000 | |
| Cash Change | -32.116 M | 119.628 M | -119.428 M | 23.979 M | -32.763 M | 9.877 M | -14.517 M | 13.873 M |